Plants survive cold by adjusting at cellular level. Scientists discovered that the PORCUPINE protein helps plants adapt to ...

This leadership transition is anticipated to further Akari’s momentum in developing transformative cancer ... aims to advance Akari’s novel spliceosome inhibitor payload ADC technology and ...

This leadership transition is anticipated to further Akari’s momentum in developing transformative cancer treatments.Want deeper insights ... The private placement aims to advance Akari’s novel ...

With these funds the Company will focus on investing in its novel spliceosome inhibitor payload ADC technology platform, seeking license partners for its TROP-2 ADC program, and monetizing non ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 Events ...

– Reported Positive Overall Survival and Overall Response Rate Data from the Ongoing Phase 2 Trial of SLS009 (Tambiciclib) in r/r AML – Full Data and FDA Regulatory Path Feedback Expected in 1H 2025 – ...

Metabolic reprogramming in cancer cells could be impacted by post-translational events and epigenetic regulation of genes. RALY was identified in the spliceosome complex and in the Drosha ...

Prostate cancer (PCa) is the second most common male cancer and about ... miRNA located within of mirtrons and are associated with spliceosome-dependent mechanisms. After, the mature miRNA produced by ...

Human T47D breast cancer cells were purchased from American Type Culture ... which is required for the binding of the U1 protein of the spliceosome. Imaging and biochemical experiments were carried ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...